NO20055136L - Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer - Google Patents

Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer

Info

Publication number
NO20055136L
NO20055136L NO20055136A NO20055136A NO20055136L NO 20055136 L NO20055136 L NO 20055136L NO 20055136 A NO20055136 A NO 20055136A NO 20055136 A NO20055136 A NO 20055136A NO 20055136 L NO20055136 L NO 20055136L
Authority
NO
Norway
Prior art keywords
immunosuppressant
treatment
pharmaceutical composition
skin disorders
combinations
Prior art date
Application number
NO20055136A
Other languages
English (en)
Other versions
NO20055136D0 (no
Inventor
Stefan Hirsch
Friedrich Karl Mayer
Nabila Sekkat
Carle Paul
Carl-Martin Weiss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055136D0 publication Critical patent/NO20055136D0/no
Publication of NO20055136L publication Critical patent/NO20055136L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives synergistiske kombinasjoner av en makrolid T-celle immunomodulator eller -immunosuppresant som 33-epiklor-33-desoksyaskomycin og et mykningsmiddel som dimetikon, glyserol eller isostearyl isostearat. Kombinasjonene er anvendelig særlig for behandling av dermatologiske eller mykosale sykdommer som tørr hud eller atopisk eller kontaktdermatitt.
NO20055136A 2003-04-04 2005-11-02 Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer NO20055136L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307866.4A GB0307866D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003513 WO2004087141A1 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases

Publications (2)

Publication Number Publication Date
NO20055136D0 NO20055136D0 (no) 2005-11-02
NO20055136L true NO20055136L (no) 2006-01-04

Family

ID=9956229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055136A NO20055136L (no) 2003-04-04 2005-11-02 Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer

Country Status (13)

Country Link
US (1) US20070276004A1 (no)
EP (1) EP1613314A1 (no)
JP (1) JP2006522059A (no)
CN (1) CN1767826A (no)
AU (1) AU2004226821A1 (no)
BR (1) BRPI0409187A (no)
CA (1) CA2521250A1 (no)
GB (1) GB0307866D0 (no)
IS (1) IS8105A (no)
MX (2) MXPA05010703A (no)
NO (1) NO20055136L (no)
RS (1) RS20050739A (no)
WO (1) WO2004087141A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
EP2471450A1 (en) 2005-10-14 2012-07-04 Nanostim, Inc. Leadless cardiac pacemaker and system
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
WO2012051237A1 (en) 2010-10-12 2012-04-19 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
CN103249454A (zh) 2010-10-13 2013-08-14 内诺斯蒂姆股份有限公司 带有防旋出构造的无引线心脏起搏器
EP2651494B1 (en) 2010-12-13 2017-02-15 Pacesetter, Inc. Delivery catheter
EP2651502B1 (en) 2010-12-13 2016-11-09 Pacesetter, Inc. Pacemaker retrieval systems
WO2012088118A1 (en) 2010-12-20 2012-06-28 Nanostim, Inc. Leadless pacemaker with radial fixation mechanism
AU2012223245A1 (en) * 2011-03-03 2013-09-19 Allergan, Inc. Non-aqueous silicone-based ophthalmic formulations
US9511236B2 (en) 2011-11-04 2016-12-06 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
EP2879758B1 (en) 2012-08-01 2018-04-18 Pacesetter, Inc. Biostimulator circuit with flying cell
WO2016150417A1 (de) * 2015-03-25 2016-09-29 Gct Gmbh Kosmetisches produkt sowie konzentrat zur herstellung des kosmetischen produktes
CA3020157C (en) * 2016-04-04 2024-01-16 Drug Delivery Solutions Limited Topical composition comprising tacrolimus
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
MX2024005473A (es) * 2021-12-16 2024-05-22 Procter & Gamble Composicion acondicionadora para el cabello.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
NZ331824A (en) * 1994-10-26 2000-01-28 Novartis Ag use of an unsaturated fatty alcohol to stabilise a macrolide in a pharmaceutical composition
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
ATE279185T1 (de) * 1995-12-28 2004-10-15 Mitsubishi Pharma Corp 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-di l enthaltendes arzneimittel zur topischen anwendung zur behandlung von erkrankungen die durch eine störung des immunsystems hervorgerufen werden
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
JP4057234B2 (ja) * 1997-08-18 2008-03-05 ノイブルグ スキン ケア ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 泡状スキンクリーム、泡状スキンプロテクションクリームの使用及びその製造方法
PT2198858E (pt) * 1998-03-26 2011-09-01 Astellas Pharma Inc Composição farmacêutica de libertação constante que contém um macrólido como o tacrolimus
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP2001064164A (ja) * 1999-06-23 2001-03-13 Health Science Center:Kk 止痒皮膚塗布剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20070276004A1 (en) 2007-11-29
WO2004087141B1 (en) 2005-01-06
RS20050739A (sr) 2007-11-15
JP2006522059A (ja) 2006-09-28
EP1613314A1 (en) 2006-01-11
CN1767826A (zh) 2006-05-03
MXPA05010703A (es) 2005-12-12
BRPI0409187A (pt) 2006-04-11
CA2521250A1 (en) 2004-10-14
WO2004087141A1 (en) 2004-10-14
MXPA05010708A (es) 2005-12-12
IS8105A (is) 2005-10-31
AU2004226821A1 (en) 2004-10-14
NO20055136D0 (no) 2005-11-02
GB0307866D0 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
MXPA05010708A (es) Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel.
WO2008127373A3 (en) Methods and devices for treating tissue
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
WO2010070675A3 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
NO20090305L (no) Cyklosporin formuleringer
WO2006015263A3 (en) Lonidamine analogs
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
BRPI0412989A (pt) combinação farmacêutica útil para mobilização de célula-tronco
BR0307211A (pt) Composições tópicas possuindo um ingrediente natural e método de utilização
WO2005060960A3 (en) Use of histamine to treat bone disease
DK1146886T3 (da) Sojaekstrakt indeholdende lipider, fremgangsmåde til fremstilling heraf og farmaceutisk og kosmetisk sammensætning
WO2008049903A3 (en) Wide-area parasystemic treatment of skin related conditions
TW200801031A (en) Steroid nitrooxyderivatives
WO2008050157A3 (en) Ozonated oil formulations
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
WO2006018454A3 (de) Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen
NO20053903L (no) Nukleotidlipidesterderivater.
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
WO2008034989A3 (fr) Utilisation d'un extrait de quinoa comme actif cosmetique et pharmaceutique amincissant et/ou comme actif prevenant de la formation de nouvelles graisses dans le corps humain
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application